Press releases | WebDisclosure

Basculer en Français

10259	Companies
212155	Keywords
141962	Articles
112337	Press releases

Home
Press releases

PRESS RELEASE

published on 09/30/2025 at 00:30, 6 months 22 days ago

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC
Nanobiotix announces updated phase 1 results supporting JNJ-1900 plus anti-PD-1 as a new option in R/M-HNSCC. Promising local and systemic responses presented at ASTRO 2025

NANOBIOTIX Anti-PD-1 JNJ-1900 R/M-HNSCC ASTRO 2025
PRESS RELEASE

published on 09/29/2025 at 23:30, 6 months 22 days ago

55 North Mining Inc. Announces Consolidation of Shares
55 North Mining Inc. announces a consolidation of common shares on a 12.5:1 basis, reducing outstanding shares. No fractional shares issued. Record date Oct 3, 2025, on CSE approval

Common Shares Consolidation Record Date CSE 55 North Mining Inc.
PRESS RELEASE

published on 09/29/2025 at 23:20, 6 months 22 days ago

Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 2025
Clean Air Metals Inc. announces filing of unaudited consolidated interim financial statements for the six-month period ended July 31, 2025. Details available on SEDAR+ website

Financial Statements Exploration Activities Clean Air Metals Thunder Bay North Project SEDA+
PRESS RELEASE

published on 09/29/2025 at 23:10, 6 months 22 days ago

McKay Brothers Launches Fastest Private Transport for Crypto & FX Trading Between London and Singapore
McKay Brothers launches fastest private transport service for crypto & FX trading between London and Singapore, providing low-latency connection to leading platforms. Attendees can visit McKay at Token 2049 conference

London Singapore Crypto McKay Brothers Private Transport FX Trading
PRESS RELEASE

published on 09/29/2025 at 23:05, 6 months 22 days ago

Green Bridge Metals Announces Non-Brokered Private Placement
Green Bridge Metals Corporation plans $6,000,000 non-brokered private placement to fund operations and working capital. Units priced at $0.09 each with potential future growth

Private Placement Working Capital Finders' Fees Green Bridge Metals Battery Metal
PRESS RELEASE

published on 09/29/2025 at 23:00, 6 months 22 days ago

Informations privilégiées / Communiqué sur comptes, résultats
GenSight Biologics publie résultats financiers du premier semestre 2025 : gestion optimisée de trésorerie, financement post-clôture, transfert de fabrication, protocole d'étude soumis à l'ANSM

Résultats Financiers Financement Trésorerie GenSight Biologics Étude ANSM
PRESS RELEASE

published on 09/29/2025 at 23:00, 6 months 22 days ago

Inside Information / News release on accounts, results
GenSight Biologics reports 8.3% reduction in operating cash outflow and extends cash runway to late Q4 2025. Company's financial results show decrease in operating income, R&D expenses, and net cash flows

Financial Results Operating Income Cash Management GenSight Biologics R&D Expenses
PRESS RELEASE

published on 09/29/2025 at 22:10, 6 months 22 days ago

Nautical Ventures Expands Electric Division with Exclusive Taiga Personal Watercraft Distribution in Florida
Vision Marine Technologies through Nautical Ventures partners with Taiga Motors for exclusive distribution of electric personal watercraft in Florida markets, enhancing its Electric Division

Vision Marine Technologies Florida Market Nautical Ventures Electric Watercraft Taiga Motors
PRESS RELEASE

published on 09/29/2025 at 22:05, 6 months 22 days ago

Abivax annonce l’acceptation d’un « late-breaking » abstract supplémentaire sur les essais d'induction ABTECT de phase 3, qui sera présenté à l'occasion de la semaine United European Gastroenterology
Abivax annonce l'acceptation d'un nouvel abstract sur les essais d'induction ABTECT de phase 3 pour la rectocolite hémorragique modérément à sévèrement active, à présenter à la semaine UEG

Abivax Rectocolite Hémorragique ABTECT UEG Essais D'induction
PRESS RELEASE

published on 09/29/2025 at 22:05, 6 months 22 days ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces acceptance of additional late-breaking abstract from the ABTECT Phase 3 induction trials to be presented at 2025 United European Gastroenterology (UEG) Meeting

Abivax Ulcerative Colitis Gastroenterology Late-breaking Abstract ABTECT Phase 3

Accesswire

Published on 04/22/2026 at 01:55, 9 hours 10 minutes ago

Immutable Holdings Announces Director Resignation
Published on 04/22/2026 at 01:30, 9 hours 35 minutes ago

Challenger West Assays Return Grades up to 60g/t Au
Published on 04/22/2026 at 00:55, 10 hours 10 minutes ago

Gold Port Announces Option Grants
Published on 04/22/2026 at 00:00, 11 hours 5 minutes ago

Zimtu Capital Corp. and Global Energy Metals Corporation Agree to Terminate Option Agreement for the Monument Peak Copper-Silver Project, Idaho
Published on 04/22/2026 at 00:00, 11 hours 5 minutes ago

Grande Portage Resources Announces SEDAR+ Filing of Preliminary Economic Assessment (PEA) Study for the New Amalga Gold Project in SE Alaska

View all ACCESSWIRE

EQS Group

Published on 04/22/2026 at 10:32, 33 minutes ago

EQS-Adhoc: K+S Aktiengesellschaft: EBITDA and adjusted free cash flow in the first quarter of 2026 significantly above market expectations; EBITDA forecast for the full year 2026 raised
Published on 04/22/2026 at 10:18, 47 minutes ago

Successful Listing on the Primary Market of Düsseldorf Stock Exchange Strengthens Capital Market Position and Growth Strategy
Published on 04/22/2026 at 10:00, 1 hour 5 minutes ago

Vossloh to supply railway project in Tanzania
Published on 04/22/2026 at 09:35, 1 hour 30 minutes ago

Iconic British Brand Laura Ashley launches Four Fragrances Inspired by Archival Prints
Published on 04/22/2026 at 09:19, 1 hour 46 minutes ago

EQS-Adhoc: TUI expects to report underlying EBIT for Q2 FY 2026 ahead of prior year, but adjusts FY 2026 underlying EBIT guidance at constant currency due to the continuing Iran war

Les Echos

Published on 04/22/2026 at 07:00, 4 hours 5 minutes ago

Chiffre d'affaires 1er trimestre 2026. 229,5M€ à devises constantes. 215,5 M€ à devises courantes.
Published on 04/22/2026 at 07:00, 4 hours 5 minutes ago

Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/22/2026 at 06:55, 4 hours 10 minutes ago

Een kwartaal met twee gezichten
Published on 04/22/2026 at 06:55, 4 hours 10 minutes ago

Two Seasons In One Quarter
Published on 04/21/2026 at 19:15, 15 hours 50 minutes ago

AXA - Description of the Company’s share repurchase program

View all LES ECHOS COMFI WIRE